GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.710
-0.040 (-1.45%)
At close: Dec 5, 2025, 4:00 PM EST
2.711
+0.001 (0.04%)
After-hours: Dec 5, 2025, 7:34 PM EST
GoodRx Holdings Revenue
GoodRx Holdings had revenue of $196.03M in the quarter ending September 30, 2025, with 0.40% growth. This brings the company's revenue in the last twelve months to $800.65M, up 1.30% year-over-year. In the year 2024, GoodRx Holdings had annual revenue of $792.32M with 5.61% growth.
Revenue (ttm)
$800.65M
Revenue Growth
+1.30%
P/S Ratio
1.24
Revenue / Employee
$1,084,893
Employees
738
Market Cap
919.86M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GDRX News
- 18 days ago - GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy® - Business Wire
- 4 weeks ago - GoodRx Holdings, Inc. (GDRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - GoodRx Sees ‘Profund Transformation' in Prescriptions With TrumpRx - PYMNTS
- 4 weeks ago - GoodRx Reports Third Quarter 2025 Results - Business Wire
- 4 weeks ago - Should You Buy GoodRx Stock? - Forbes
- 7 weeks ago - GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment - Business Wire
- 2 months ago - GoodRx: Novo Deal And TrumpRx Talks Point To Ebitda/FCF Upside - Seeking Alpha
- 2 months ago - Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch - Benzinga